Domenica Lorusso

46PUBLICATIONS
268CO-AUTHORS
Predictive and prognostic markersCancer cell biologyMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Sep 14, 2026
Differentiating high- and low-grade serous ovarian carcinoma using radiomics: a pilot study.

|May 22, 2026
Signaling Under Stress: Targeting the Glucocorticoid Receptor in Cancer.

|May 15, 2026
Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses.

|Dec 30, 2025
Management of Patients with Epithelial Ovarian Cancer: A Systematic Comparison of International Guidelines from Scientific Societies (AIOM-BGCS-ESGO-ESMO-JGSO-NCCN-NICE).

Martina Arcieri, Veronica Tius, Sara Filippin

|Nov 24, 2025
Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian Cancer.

Claudia Marchetti, Gwenael Ferron, Olivier Colomban

|Aug 27, 2025
Preclinical Activity of Datopotamab Deruxtecan (Dato-DXd), an Antibody-Drug Conjugate Targeting TROP2, in Poorly Differentiated Endometrial Carcinomas.

Niccolò G Santin, Namrata Sethi, Stefania Bellone

Pageof 8

Frequent Collaborators

10 joint publications

Nicoletta Colombo

8 joint publications

Bradley J Monk

7 joint publications

Ana Oaknin

7 joint publications

Giovanni Scambia